Trial Profile
A Randomised, Placebo-Controlled, Double-Blind, Single Dose Escalation Study to evaluate the Safety, Tolerability and Pharmacokinetics of Betahistine Dihydrochloride Following a Single Intranasal Dose in Healthy Male and Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Betahistine (Primary)
- Indications Otitis media
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Otifex Therapeutics
- 31 Jul 2015 New trial record